Trace Genomics Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
40
- Latest Deal Type
-
M&A
Trace Genomics General Information
Description
Operator of a soil analytics engine intended to offer comprehensive soil biology and chemistry analysis to its clients. The company analyzes the soil's biology by applying proprietary soil Deoxyribonucleic Acid (DNA) extraction and sequencing to index and quantify microbes thereby decoding the soil biological data and comparing it with soil chemical data to give informed soil insights, enabling farmers to make informed decisions, optimize costs, manage risk and protect their soil as a capital asset.
Contact Information
Website
www.tracegenomics.comCorporate Office
- 615 South Bell Avenue
- Ames, IA 50010
- United States
Corporate Office
- 615 South Bell Avenue
- Ames, IA 50010
- United States
Trace Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 07-Jul-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B) | 20-Feb-2024 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 01-Feb-2022 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B) | 23-Nov-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A) | 08-Jul-2020 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | 14-Dec-2018 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | Completed | Startup | ||||
| 3. Accelerator/Incubator | 19-May-2016 | Completed | Startup | |||
| 2. Accelerator/Incubator | 04-Apr-2016 | Completed | Startup | |||
| 1. Accelerator/Incubator | 05-Aug-2015 | Completed | Startup |
Trace Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A5 | ||||||||
| Series A4 | ||||||||
| Series A3 | ||||||||
| Series A2 | ||||||||
| Series A1 | 1,532,034 | $0.000100 | 8% | $1.35 | $1.35 | 1x | $1.35 | 1.6% |
| Series A | 10,638,048 | $0.000100 | 8% | $1.51 | $1.51 | 1x | $1.51 | 11.13% |
Trace Genomics Comparisons
Industry
Financing
Details
Trace Genomics Competitors (12)
One of Trace Genomics’s 12 competitors is Taranis, a Venture Capital-Backed company based in Tel Aviv, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Taranis | Venture Capital-Backed | Tel Aviv, Israel | ||||
| Biome Makers | Venture Capital-Backed | Davis, CA | ||||
| SourceTrace | Venture Capital-Backed | Cambridge, MA | ||||
| AgroCares | Formerly PE-Backed | Wageningen, Netherlands | ||||
| Intelinair | Venture Capital-Backed | Indianapolis, IN |
Trace Genomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Trace Genomics Patents
Trace Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3216192-A1 | Precision farming system with scaled soil characteristics | Pending | 12-Oct-2022 | ||
| CA-3216196-A1 | Precision farming system with sustainability measure | Pending | 12-Oct-2022 | ||
| CA-3142568-A1 | Microbial quantitation | Pending | 03-Jun-2019 | ||
| WO-2020247525-A1 | Microbial quantitation | Inactive | 03-Jun-2019 | ||
| WO-2020176464-A1 | Soil health indicators using microbial functional genes | Inactive | 25-Feb-2019 | G01N33/24 |
Trace Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Trace Genomics Former Investors (31)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 100+ Accelerator | Accelerator/Incubator | Minority | ||
| ATEL Capital Group | Asset Manager | Minority | ||
| AgFunder | Venture Capital | Minority | ||
| Ajax Strategies | Impact Investing | Minority | ||
| Alexandria Venture Investments | Venture Capital | Minority |
Trace Genomics Investments (1)
Trace Genomics’s most recent deal was a Corporate Asset Purchase with WinField United (Soil Processing Assets). The deal was made on 06-Mar-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| WinField United (Soil Processing Assets) | 06-Mar-2020 | Corporate Asset Purchase | Buildings and Property |
Trace Genomics FAQs
-
When was Trace Genomics founded?
Trace Genomics was founded in 2015.
-
Where is Trace Genomics headquartered?
Trace Genomics is headquartered in Ames, IA.
-
What is the size of Trace Genomics?
Trace Genomics has 40 total employees.
-
What industry is Trace Genomics in?
Trace Genomics’s primary industry is Media and Information Services (B2B).
-
Is Trace Genomics a private or public company?
Trace Genomics is a Private company.
-
What is Trace Genomics’s current revenue?
The current revenue for Trace Genomics is .
-
How much funding has Trace Genomics raised over time?
Trace Genomics has raised $59.8M.
-
Who are Trace Genomics’s investors?
100+ Accelerator, ATEL Capital Group, AgFunder, Ajax Strategies, and Alexandria Venture Investments are 5 of 31 investors who have invested in Trace Genomics.
-
Who are Trace Genomics’s competitors?
Taranis, Biome Makers, SourceTrace, AgroCares, and Intelinair are some of the 12 competitors of Trace Genomics.
-
When was Trace Genomics acquired?
Trace Genomics was acquired on 07-Jul-2025.
-
Who acquired Trace Genomics?
Trace Genomics was acquired by Miraterra Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
